April 2, 2026
Mastering the Pharmacovigilance System Master File (PSMF): A Guide to Inspection...
Explore the purpose of the PSMF, why it is vital during inspections, common regulatory findings, and best practices for keeping it inspection-ready.
ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.
Evaluating research platform capabilities for specific life sciences use cases can be complex, and challenges often persist when the software is implemented due to a lack of time, personnel, and in-house expertise.
Our consultants are Benchling specialists, which means we can provide strategic guidance and continually support your Benchling ecosystem according to both your short-term and long-term goals. This can include creating training tailored for your specific use cases to support user adoption and providing insights into effective change management strategies to help communicate the value the new platform can provide to their daily work.
As your R&D science advances, workflows and reporting processes will also change and mature. Whether your business grows organically or through mergers and acquisitions, these natural progressions require appropriate adjustments to your supporting technologies, including Benchling configurations.
ProPharma can provide consultation and other support services to ensure your Benchling platform is maximized to support existing and future workflows as well as extending the platform to new user groups.
Advances in Benchling features are constantly occurring; however, these additions or enhancements may require new system configurations, processes, and/or training to ensure full utilization and return on investment.
As a Benchling partner, we can help assess, advise, and configure new Benchling software releases for your use cases. Our consultants have deep scientific domain knowledge and laboratory experience as well as business consulting expertise which help us ensure your configured platform is fit-for-purpose.
Although it is sometimes overlooked, maintaining and upgrading a research platform on an ongoing basis can create a significant resource burden. R&D scientists have numerous priorities, and managing and supporting software should not be one of them. Our team of Benchling specialists can mitigate the time and resource constraints associated with managing your research platform by providing ongoing support services for all your Benchling needs.
ProPharma is committed to improving the health and safety of patients by delivering the highest quality solutions and services throughout the full product lifecycle, including solving the complex challenges associated with data and technology. Our R&D Technology consultants combine scientific knowledge with hands-on laboratory research and technology expertise.
We have extensive experience supporting Benchling end-to-end solutions for the following:
Our combination of scientific knowledge, hands-on laboratory research, and technology expertise allows us to truly understand your needs and help ensure data protection, integrity, and utility. This agile and scalable approach enables us to deliver customized services that optimize results.
Project scoping, requirements gathering, document generation, and overall system assessment
Project scoping, requirements gathering, document generation, and overall system assessment
Read LessOngoing data governance, maintenance, and support of test and production environments
Ongoing data governance, maintenance, and support of test and production environments
Read LessData model configuration changes and refreshes
Data model configuration changes and refreshes
Read LessOffice hours for users to ask questions, receive support, and gain knowledge of the platform
Office hours for users to ask questions, receive support, and gain knowledge of the platform
Read LessGenerating client-tailored training materials, customized for your specific use cases, to help ensure your team is using the Benchling platform to its fullest potential
Generating client-tailored training materials, customized for your specific use cases, to help ensure your team is using the Benchling platform to its fullest potential
Read Less
Contact us today to learn more about our Benchling services or speak with one of our experts.
Senior R&D Technology Manager
View Bio
Solutions Consultant
View Bio
April 2, 2026
Explore the purpose of the PSMF, why it is vital during inspections, common regulatory findings, and best practices for keeping it inspection-ready.
March 30, 2026
Discover how multilingual contact centers enhance accessibility for MAHs, offering scalable solutions from front-desk support to full Medical Information services.
January 27, 2026
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
December 11, 2025
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 9, 2024
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
March 30, 2026
Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...
March 23, 2026
Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...
April 23, 2026
As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...
April 9, 2026
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...
April 9, 2026
As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...